Anticorpi Rel B

8 prodotti

Rel B è un gene codificato dal simbolo RELB. È noto anche come: Transcription factor RelB; I-Rel; RELB. Rel B ha una massa di 62.13kDa, una lunghezza di amminoacidi di 579, ed è implicato in Immunodeficiency 53.

Offriamo 8 anticorpi contro Rel B, allevati nel Coniglio e Topo, che sono adatti per WB, IHC, ELISA, ICC/IF e IP con campioni derivati ​​da Umano, Topo e Ratto.

Informazioni su geni e proteine

Riepilogo UniProt
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed:26385063).
Coinvolgimento nella malattia
Immunodeficiency 53: An autosomal recessive primary immunodeficiency apparent from early infancy and resulting in recurrent infections, severe autoimmune skin disease rheumatoid arthritis, and failure to thrive. Immunologic workup shows increased CD4+/CD8+ ratio, impaired T-cell proliferative response to multiple antigen, T-cell developmental and functional defects, and impaired ability to produce specific immunoglobulins.
Modifica post-translazionale
Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.
Posizione cellulare
Nucleus. Cytoplasm > Cytoskeleton > Microtubule organizing center > Centrosome.

Colocalizes with NEK6 in the centrosome.
Segnaposto immagine Antibodies.com - Scopri di più spendendo meno
Immunohistochemistry - Anti-RelB (phospho Ser552) Antibody (A7212) - Antibodies.com
(2)
Visualizza prodotto10µg Dimensione di prova
Western Blot - Anti-Rel B Antibody (A11158) - Antibodies.com
(4)
Western Blot - Anti-RelB Antibody (B7212) - Antibodies.com
Visualizza prodotto10µg Dimensione di prova
Western blot - RelB (Phospho-Ser573) Antibody from Signalway Antibody (11255) - Antibodies.com
(2)
Western blot - RelB (Ab-573) Antibody from Signalway Antibody (21247) - Antibodies.com
RELB Antibody from Signalway Antibody (37866) - Antibodies.com
Anti-Rel B (S552) Antibody from Bioworld Technology (BS70007) - Antibodies.com

Mostra 1-8 di 8 prodotti

Filtri Menù Principale Contattaci 0Check-out
Inizio pagina